Aberdeen Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.2M | Buy |
|
|||||
|
2025
Q2 | $778K | Buy |
|
|||||
|
2025
Q1 | $528K | Sell |
|
|||||
|
2024
Q4 | $3.29M | Sell |
|
|||||
|
2024
Q3 | $3.71M | Sell |
|
|||||
|
2024
Q2 | $25.8M | Buy |
|
|||||
|
2024
Q1 | $30.3M | Sell |
|
|||||
|
2023
Q4 | $28.8M | Buy |
|
|||||
|
2023
Q3 | $2.46M | Sell |
|
|||||
|
2023
Q2 | $2.72M | Sell |
|
|||||
|
2023
Q1 | $2.64M | Sell |
|
|||||
|
2022
Q4 | $2.85M | Buy |
|
|||||
|
2022
Q3 | $2.38M | Buy |
|
|||||
|
2022
Q2 | $2.6M | Sell |
|
|||||
|
2022
Q1 | $3.59M | Sell |
|
|||||
|
2021
Q4 | $5.57M | Sell |
|
|||||
|
2021
Q3 | $6.59M | Buy |
|
|||||
|
2021
Q2 | $4.86M | Buy |
|